Core Viewpoint - The launch of the domestically produced calcipotriene and betamethasone ointment by Chongqing Huabang Pharmaceutical on JD Health marks a significant advancement in psoriasis treatment options for patients in China, providing a more accessible and effective solution [1][2] Group 1: Product Overview - The calcipotriene and betamethasone ointment is the first generic version in China, equivalent to the original product, enhancing treatment options for psoriasis patients [1] - The ointment combines calcipotriene, which inhibits abnormal proliferation of keratinocytes and promotes normal differentiation, with betamethasone, known for its strong anti-inflammatory and immunosuppressive effects [1] Group 2: Market Impact - The product's launch on JD Health signifies an important upgrade in the collaboration between Huabang Pharmaceutical and JD Health, leveraging JD Health's extensive user base and comprehensive healthcare service system [2] - JD Health's capabilities in online consultation, drug delivery, and health management will enhance the market coverage and user reach of the new ointment, benefiting more patients [2]

近日，国产药物臣可舒®(通用名：丙酸氟替卡松雾化吸入用混悬液)在京东健康线上首发。这款药物是 治疗儿童及青少年哮喘急性发作的雾化吸入用糖皮质激素(ICS)，由上海新黄河制药有限公司生产，为 哮喘患者带来更高效、更安全的治疗选择。京东健康将充分发挥自身全渠道优势与医疗健康服务能力， 加速新药普及，助力提升儿童呼吸疾病管理的体验。 丙酸氟替卡松雾化吸入用混悬液是新一代雾化ICS，其药物分子结构引入独特化学基团，显著增强了药 物的抗炎活性，同时降低了对下丘脑-垂体-肾上腺(HPA)轴的抑制，提升了安全性。 针对儿童哮喘药物治疗的高安全性需求，丙酸氟替卡松具有高肝脏首过代谢率(99%)和极低口服生物利 用度(≤1%)的特点，在发挥局部抗炎作用的同时，能最大限度地减少药物经消化道进入全身血液循环的 浓度，降低全身不良反应及对儿童生长发育的影响，适合儿童包括低龄儿童使用。此次线上首发的新品 臣可舒®(丙酸氟替卡松雾化吸入用混悬液)，采用2ml:0.5mg*5支/袋*2袋/盒的规格设计，兼顾疗效与用 药便利性，为临床提供了灵活治疗方案。 ICS是国内外权威指南一致推荐的首选抗炎药物，臣可舒®是抗炎强效、儿童安全的雾化ICS ...

Group 1 - The core viewpoint of the articles highlights the launch of Santen's flagship product, Vitamin B12 Eye Drops (Santen Rose®), on JD Health, emphasizing its upgraded design and effectiveness in alleviating visual fatigue [1][2] - The product is backed by clinical research showing a 66.1% efficacy rate in patients using the eye drops alone, compared to 62.5% in those using a combination treatment [2] - JD Health aims to leverage its extensive user base and comprehensive healthcare service system to enhance the market reach and accessibility of Santen Rose® [2] Group 2 - The launch coincides with the increasing prevalence of visual fatigue due to the "screen reading era," creating significant demand for eye drops among younger consumers [1] - Santen Rose® is imported from Japan and packaged in a GMP-certified facility, ensuring high quality and user-friendly design [1] - JD Health's commitment to user health needs and its strategic partnership with Santen will facilitate easier access to this professional eye care product for consumers [2]

野村升京东健康目标价至49港元 受惠京东外卖投资 金十数据6月9日讯，野村发表报告指，京东健康(06618.HK)受惠于京东(09618.HK)进取的外卖投资，目 标价由44港元升至49港元，评级买入。报告指，京东健康的母公司京东于2月进入食品配送市场，并在4 月透过积极的促销和策略性行销活动大幅提升其市场占有率。京东最近的数据显示，在10万名全职骑手 网络的支持下，每天的外送订单超过2500万份，并在客户采用外卖及其配送网络能力方面均录得稳定增 长。 ...

Core Insights - The "2025 JD Health - Eye Health Industry Summit" was held to promote scientific eye care concepts and explore new user needs and industry trends in the ophthalmology field [1][2] - JD Health aims to enhance patient understanding of eye diseases and expand service boundaries for doctors, leveraging its position as a comprehensive retail channel for ophthalmic medications in China [1][2] Industry Trends - The prevalence of eye health issues is rising due to increased use of electronic devices and fast-paced lifestyles, with approximately 2.2 billion people globally facing vision problems according to WHO [1] - Key trends in eye health include the increasing incidence of myopia among youth, widespread dry eye disease, and the combination of visual fatigue with chronic inflammation [2] Digital Health Solutions - JD Health's online platform has integrated nearly 2,000 top-tier ophthalmologists, providing 24/7 online consultation services with an average response time of 30 seconds [2] - The company has seen significant growth in its ophthalmic medication sales, with a compound annual growth rate of 31.7% over the past three years and a year-on-year growth rate of 56.5% in the first five months of 2025 [4] Consumer Behavior - The "New Generation of Eye Health" white paper indicates that consumer demand for ophthalmic medications is characterized by high frequency and diversity, although adherence to treatment remains a challenge [4] - Online channels, particularly internet hospitals, are accelerating the entire process of understanding, researching, and purchasing eye medications, with a reported increase in consultation rates by over 20% [4] Strategic Partnerships - Companies like Zhenzhiming Pharmaceutical and Santen are leveraging JD Health's platform for B2C and O2O business integration, enhancing brand visibility and meeting consumer demands for immediate access to medications [3] - JD Health is positioned as a launch platform for new ophthalmic products, integrating supply chain, logistics, and digital capabilities to meet user needs effectively [5] Future Developments - JD Health plans to expand its supply chain capabilities and enhance its product offerings for various eye conditions, aiming to create a comprehensive eye health protection system that spans prevention, diagnosis, and rehabilitation [6]

Group 1 - The "Healthy Childhood, Nurturing the Future" 2025 Children's Health Science Popularization Initiative was launched by JD Health in Beijing, with participation from pediatric experts and representatives from various pharmaceutical companies [1][2] - JD Health aims to provide scientific parenting support by utilizing internet hospitals to conduct live broadcasts on topics such as flu prevention, nutritional supplementation, and psychological growth during Children's Day [1][2] - The initiative addresses the increasing demand from parents for children's health management due to changes in living environments and lifestyles, with JD Health focusing on reducing illness and ensuring safer medication for children [1][2] Group 2 - JD Health has established a comprehensive pediatric medication supply chain covering various categories, including gastrointestinal, respiratory, and rare disease medications, to meet diverse family health needs [2] - The company plans to expand its pediatric medication offerings by introducing inhalants and granules specifically for children, as well as prescription drugs and innovative treatments, enhancing the accessibility of local medications [2] - JD Health intends to leverage its leading position in online health consumption to provide data support for the development, production, and sales of children's medications, while also offering CRM tools to pharmaceutical companies for better user service [2][3] Group 3 - JD Health will utilize its self-developed "JD Medical Inquiry" AI model to assist hospitals and medical institutions in building a comprehensive management platform for pediatric diseases, enhancing educational outreach through AI digital personas [3]

Core Viewpoint - The "Healthy Childhood: Nurturing the Future" 2025 Children's Health Science Popularization Initiative was launched by JD Health, aiming to enhance children's health education and support families in scientific parenting [1][3]. Group 1: Initiative Launch and Objectives - The initiative was launched on May 29, ahead of Children's Day, with participation from pediatric experts and representatives from various pharmaceutical companies [1]. - JD Health plans to collaborate with leading medical institutions to conduct a series of educational live streams focusing on children's health topics such as flu prevention, nutrition, and psychological growth [1][3]. Group 2: Industry Collaboration and Expert Insights - The initiative addresses the increasing demand from parents for children's health management due to changing lifestyles and environments [3]. - Experts emphasized the importance of integrating various resources through internet medical platforms to enhance health education dissemination [3]. - Pharmaceutical representatives highlighted their commitment to responsible branding and innovation in children's medication [3][4]. Group 3: Comprehensive Health Service Framework - JD Health has established a comprehensive pediatric medication supply chain covering various health needs, including nutrition, respiratory medications, and rare disease treatments [4]. - The "China Children's Care Program" will provide parents with 24/7 consultation services via the JD app, facilitating experience sharing among parents [5]. Group 4: Future Plans and Innovations - JD Health aims to focus on clinical pain points in children's medication, leveraging its supply chain and AI capabilities to enhance service delivery [7]. - The company plans to expand its pediatric medication offerings, including inhalants and innovative drugs, to improve accessibility for families across the country [7]. - JD Health will utilize its proprietary AI model to assist healthcare institutions in building comprehensive management platforms for children's health [7][8]. Group 5: Commitment to Holistic Health Solutions - The initiative underscores the belief that safeguarding children's health is foundational to overall public health [8]. - JD Health seeks to collaborate with partners in various fields to meet children's health needs comprehensively, ensuring reliable and accessible health services for families [8].

京东健康作为行业领先的医疗健康服务企业，拥有庞大的用户基础，并构建了完善的医疗健康服务体 系，包括在线问诊、药品配送、健康管理等一站式服务。这些优势将有助于显著提升八珍益母片新品的 市场覆盖率和用户触达率。 京东健康医药业务部相关负责人表示，京东健康一直致力于为消费者提供优质的医药健康产品和服务， 八珍益母片作为妇科领域的经典中成药，赢得了广泛的市场认可。相信通过双方的携手合作，将帮助更 多女性用户便捷获取这一优质产品，让传统中医药更好地满足现代女性的健康需求。 编辑：王菁 此次在京东健康线上首发的千金八珍益母片新品，精选当归、党参、川芎、熟地黄、童子益母草等九味 道地药材，配合超微粉碎等现代技术，确保药材活性成分保留率超90%，生物利用度提升68%。同时， 通过专利工艺处理，使芍药苷等有效成分含量达到国家药典标准的2.3倍，显著提升了药物疗效。 临床试验数据显示，针对月经量少（＜20ml／周期）、经血色淡、经期延长（＞7天）伴面色萎黄、乏 力懒言等典型气血两虚证候，千金八珍益母片新规产品总有效率达91.2%。此外，产品不仅适用于产 后、更年期、术后等气血亏虚状态，还为职场白领、健身达人、节食减肥人群提供亚健 ...

Group 1 - The event "Happy Heart Universe: Happiness Exchange" was held on National Mental Health Day, attracting over 3,000 participants, including university students and teachers from affiliated primary and secondary schools [1][2] - The collaboration between Beijing Jiaotong University and JD Health aims to enhance mental health awareness and create a positive campus environment through interactive games and activities [1][2] - The "Rainbow Hug" campus run was a highlight, with over 400 students participating, showcasing a vibrant and dynamic atmosphere [2] Group 2 - The importance of mental health for students is emphasized, with 80% of their time spent online, and the university aims to provide more channels for psychological assistance through "Internet+" initiatives [3] - JD Health has established a comprehensive mental health service system across multiple universities, offering a full-service loop from assessment to treatment [4] - The integration of over 6,000 psychiatrists and 2,000 psychological counselors supports the provision of both online and offline mental health services for students [4] Group 3 - JD Health plans to continue exploring new models and pathways for campus mental health services by connecting schools, medical institutions, and families [5]

Core Points - The launch of the new 18.4g box of Longhu Brown Cooling Oil on JD Health marks a significant step for the century-old brand, leveraging JD Health's multi-channel advantages to enhance consumer purchasing experience and promote summer health [1] - Longhu Brown Cooling Oil is a well-known household remedy in China, recognized for its unique formula and effectiveness, maintaining its position as a leading brand in the cooling oil market for several consecutive years [1] - The new product offers various functions including cooling, refreshing, and pain relief, addressing discomfort from symptoms such as headaches, heatstroke, motion sickness, and insect bites [1] - The inclusion of precious ingredients like "Xuejie" (Dragon's Blood) enhances its effectiveness in relieving itching and pain, as noted in traditional Chinese medicine [1] - JD Health aims to utilize its comprehensive channel advantages and healthcare service capabilities to increase the product's market reach and brand influence [1] Company and Industry Insights - JD Health is committed to providing high-quality pharmaceutical and health products, collaborating with Longhu Brown Cooling Oil to ensure consumers can conveniently purchase this classic product [2] - The upcoming JD Health 618 shopping event coincides with the summer season, creating a timely opportunity for consumers to purchase cooling oil at discounted prices through the JD app [2]